Addex Cash per Share
ADXN Stock  USD 0.72 0.02 2.86% 
Addex Therapeutics fundamentals help investors to digest information that contributes to Addex Therapeutics' financial success or failures. It also enables traders to predict the movement of Addex Stock. The fundamental analysis module provides a way to measure Addex Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Addex Therapeutics stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Addex  Cash per Share 
Addex Cash per Share Analysis
Addex Therapeutics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
More About Cash per Share  All Equity Analysis
2020  2021  2022  2023 (projected)  
Interest Expense  650.63 K  63.01 K  313.26 K  310.16 K 
Gross Profit  3.61 M  2.92 M  1.42 M  2.16 M 
Cash per Share  =  Total Cash Average Shares 
Current Addex Therapeutics Cash per Share  1.40 X 
Most of Addex Therapeutics' fundamental indicators, such as Cash per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Addex Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Addex Cash per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Addex Therapeutics is extremely important. It helps to project a fair market value of Addex Stock properly, considering its historical fundamentals such as Cash per Share. Since Addex Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Addex Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Addex Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Addex Cash per Share Historical Pattern
Today, most investors in Addex Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Addex Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Addex Therapeutics cash per share as a starting point in their analysis.
Addex Therapeutics Cash per Share 
Timeline 
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition 
Addex Shareholders Equity Attributable to Parent
Shareholders Equity Attributable to Parent 

In accordance with the recently published financial statements, Addex Therapeutics has a Cash per Share of 1.4 times. This is 67.82% lower than that of the Healthcare sector and 67.67% lower than that of the Biotechnology industry. The cash per share for all United States stocks is 72.06% higher than that of the company.
Addex Cash per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Addex Therapeutics' direct or indirect competition against its Cash per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Addex Therapeutics could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics of similar companies.Addex Therapeutics is currently under evaluation in cash per share category among related companies.
Addex Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Addex Therapeutics from analyzing Addex Therapeutics' financial statements. These drivers represent accounts that assess Addex Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Addex Therapeutics' important valuation drivers and their relationship over time.
2018  2019  2020  2021  2022  2023 (projected)  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  (1.42 M)  (14.23 M)  (11.83 M)  (14.94 M)  (20.17 M)  (20.7 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  (1.45 M)  (14.67 M)  (13.44 M)  (16.42 M)  (21.69 M)  (22.26 M)  
Earnings before Tax  (1.64 M)  (14.78 M)  (12.86 M)  (15.35 M)  (20.8 M)  (21.35 M)  
Free Cash Flow  1.74 M  (9.51 M)  (12.24 M)  (14.74 M)  (16.44 M)  (16.87 M)  
Invested Capital  (1.79 M)  (3.64 M)  (1.57 M)  (1.6 M)  (1.58 M)  (1.71 M)  
Tangible Asset Value  42.21 M  33.03 M  20.18 M  22.54 M  8.28 M  8.5 M  
Working Capital  39.82 M  26.71 M  15.87 M  17.81 M  4.55 M  4.67 M 
Addex Fundamentals
Return On Equity  (1.90) %  
Return On Asset  (0.83) %  
Current Valuation  3.12 M  
Shares Outstanding  14.81 M  
Shares Owned by Institutions  18.00 %  
Number of Shares Shorted  673.14 K  
Price to Book  1.41 X  
Price to Sales  10.28 X  
Revenue  1.42 M  
Gross Profit  1.44 M  
EBITDA  (20.17 M)  
Net Income  (20.8 M)  
Cash and Equivalents  8.81 M  
Cash per Share  1.40 X  
Total Debt  336.95 K  
Debt to Equity  0.049 %  
Current Ratio  2.55 X  
Book Value Per Share  0.38 X  
Cash Flow from Operations  (16.44 M)  
Short Ratio  0.71 X  
Earnings Per Share  (2.26) X  
Number of Employees  24  
Beta  1.67  
Market Capitalization  13.03 M  
Total Asset  8.28 M  
Retained Earnings  (349.86 M)  
Working Capital  4.55 M  
Current Asset  32.02 M  
Current Liabilities  4.82 M  
Z Score  43.14  
Net Asset  8.28 M 
About Addex Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Addex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Addex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Addex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported  Projected for 2023  
Free Cash Flow  16.4 M  16.9 M 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Addex Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Addex Therapeutics' short interest history, or implied volatility extrapolated from Addex Therapeutics options trading.
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Addex Stock
+  0.75  KA  Kineta Inc  Symbol Change  PairCorr  
+  0.8  YS  YS Biopharma  Report 2nd of June 2023  PairCorr  
+  0.68  VACC  Vaccitech PLC ADR  Fiscal Quarter End 30th of June 2023  PairCorr 
Moving against Addex Stock
  0.72  VKTX  Viking Therapeutics  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.69  DYAI  Dyadic International  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.61  VIRI  Virios Therapeutics Llc  Buyout Trend  PairCorr  
  0.43  DVAX  Dynavax Technologies  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.42  VECT  VectivBio Holding  Trending  PairCorr 
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Altman Z Score analysis. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try RiskReturn Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Addex Stock analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets  
Focused Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences  
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated  
ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world  
Analyst Recommendations Analyst recommendations and target price estimates broken down by several categories  
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals  
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings  
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk  
Idea Analyzer Analyze all characteristics, volatility and riskadjusted return of Macroaxis ideas 
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.26)  Revenue Per Share 0.192  Quarterly Revenue Growth 0.493  Return On Assets (0.83)  Return On Equity (1.90) 
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Altman Z Score analysis. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.